Home > Human Cell Lines > Breast Cancer Cell Lines (SUM) >

SUM-102PT

 
US Price: $6,000.00

Stock Status:In Stock

Description
 
SUM-102PT

Breast cancer cell line derived at the Univeristy of Michigan, known as SUM-102PT.

SUM-102PT was derived from a primary human ductal carcinoma with evidence of micro-invasion and is a basal breast cancer cell line. The cell line is ER-, PR- and Her2+

The SUM102 cell line was developed from a patient with minimally invasive, ER negative and PR negative human breast carcinoma. The cell line is a representative of a class of human breast cancers characterized by a high level of EGFR expression in the absence of gene amplification.

Download Instruction Booklet.


***Asterand Bioscience highly suggest that frozen products are shipped utilizing a cryoport to ensure that products are maintained in a frozen state throughout the shipping process. Unless cryoport shipping is selected at checkout, all frozen products will be shipped on dry ice and scheduled for estimated 2 day delivery. All international orders of frozen products will default to cryoport shipping.***

While Asterand Bioscience takes precautions with shipping and handling, we cannot control issues due to weather, customs or other unforeseen issues. These issues may prevent the package from being delivered within the appropriate time frame for any item shipped on dry ice.